U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C20H22N2O2
Molecular Weight 322.4009
Optical Activity UNSPECIFIED
Defined Stereocenters 7 / 7
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GELSEMINE

SMILES

[H][C@@]12C[C@H]3OC[C@@H]1[C@@]4([H])N(C)C[C@]2(C=C)[C@@]4([H])[C@@]35C(=O)NC6=CC=CC=C56

InChI

InChIKey=NFYYATWFXNPTRM-QJICHLCESA-N
InChI=1S/C20H22N2O2/c1-3-19-10-22(2)16-11-9-24-15(8-13(11)19)20(17(16)19)12-6-4-5-7-14(12)21-18(20)23/h3-7,11,13,15-17H,1,8-10H2,2H3,(H,21,23)/t11-,13+,15+,16+,17-,19-,20-/m0/s1

HIDE SMILES / InChI
Gelsemine is the principal alkaloid in Gelsemium sempervirens Ait. A single intrathecal injection of gelsemine produced potent and specific antinociception in formalin-induced tonic pain, bone cancer-induced mechanical allodynia, and spinal nerve ligation-induced painful neuropathy. Gelsemine exhibits potent and specific antinociception in chronic pain by acting at spinal α3 glycine receptors. Gelsemine is an effective agent for treatment of both neuropathic pain and sleep disturbance in PSNL mice; anterior cingulate cortex might play a role in the hypnotic effects of gelsemine.

CNS Activity

Originator

Curator's Comment: Gelsemine, was first isolated by Wormley in 1870.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P24524
Gene ID: NA
Gene Symbol: Glra3
Target Organism: Rattus norvegicus (Rat)
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Indole synthesis by radical cyclization of o-alkenylphenyl isocyanides and its application to the total synthesis of natural products.
2002
Explorations in organic chemistry leading to the total synthesis of (+/-)-gelsemine.
2002 Aug 21
Gelsemine: a thought-provoking target for total synthesis.
2003 Jan 3
A convenient one-pot procedure to afford bicyclic molecules by stereospecific iron carbonyl mediated [6 + 2] ene-type cyclization: a possible approach to gelsemine.
2003 Nov 5
Use of the intramolecular Heck reaction for forming congested quaternary carbon stereocenters. Stereocontrolled total synthesis of (+/-)-gelsemine.
2005 Dec 28
Aza-cope rearrangement-mannich cyclizations for the formation of complex tricyclic amines: stereocontrolled total synthesis of (+/-)-gelsemine.
2005 Dec 28
Double conjugate addition of a nitropropionate ester to a quinone monoketal: synthesis of an advanced intermediate to (+/-)-gelsemine.
2007 Aug 2
Pattern recognition in retrosynthetic analysis: snapshots in total synthesis.
2007 Jun 8
Regulation of neurosteroid allopregnanolone biosynthesis in the rat spinal cord by glycine and the alkaloidal analogs strychnine and gelsemine.
2008 Apr 22
Nectar secondary compounds affect self-pollen transfer: implications for female and male reproduction.
2008 Aug
Steroids, alkaloids, and coumarins from Gelsemium sempervirens.
2008 Dec
A concise approach to a gelsemine core structure using an oxygen to carbon bridge swapping strategy.
2008 Nov 6
Confirmation of gelsemium poisoning by targeted analysis of toxic gelsemium alkaloids in urine.
2009 Jan-Feb
Assays of homeopathic remedies in rodent behavioural and psychopathological models.
2009 Oct
Consumption of a nectar alkaloid reduces pathogen load in bumble bees.
2010 Jan
The genus Gelsemium: An update.
2010 Jul
Dose-effect study of Gelsemium sempervirens in high dilutions on anxiety-related responses in mice.
2010 Jul
Simultaneous determination of six alkaloids in blood and urine using a hydrophilic interaction liquid chromatography method coupled with electrospray ionization tandem mass spectrometry.
2010 Oct
Antitumor activity of two gelsemine metabolites in rat liver microsomes.
2010 Sep
Patents

Patents

Sample Use Guides

In Vivo Use Guide
Curator's Comment: Oral route - Rabbits: were randomly divided into five groups and fed normal diet, hypercholesterolemic diet (1% cholesterol), or hypercholesterolemic diet (1% cholesterol) supplemented with gelsemine (1, 5, or 25 mg/kg). https://www.ncbi.nlm.nih.gov/pubmed/25213292
In PSNL mice, gelsemine (2 and 4 mg/kg) increased the mechanical threshold for 4 h and prolonged the thermal latencies for 3 h. Furthermore, gelsemine (4 mg/kg, administered at 6:30 AM) increased non-rapid eye movement (non-REM, NREM) sleep, decreased wakefulness, but did not affect REM sleep during the first 3 h in PSNL mice.
Route of Administration: Intraperitoneal
Differential concentrations of gelsemine (1, 3, 10, 30, 100, 300, and 1000 uM) or glycine (3, 10, 30, 100, 300, and 1000 uM) were added to H3 -strychnine and the rat crude membrane. Both gelsemine and glycine concentration-dependently displaced H3 -strychnine binding by a maximum displacement of 100%. The IC50 values of gelsemine and glycine were 43.8 and 82.1 uM, and their Ki values were 21.9 and 41.0 uM, respectively.
Name Type Language
GELSEMINE
MI   WHO-DD  
Common Name English
SPIRO(3,5,8-ETHANYLYLIDENE-1H-PYRANO(3,4-C)PYRIDINE-10,3'-(3H)INDOL)-2'(1'H)-ONE, 5-ETHENYL-3,4,4A,5,6,7,8,8A-OCTAHYDRO-7-METHYL-, (3R,3'S,4AR,5S,8S,8AS,9S)-
Systematic Name English
(3R-(3.ALPHA.,4A.BETA.,5.ALPHA.,8.ALPHA.,8A.BETA.,9S*,10S*))-5-ETHENYL-3,4,4A,5,6,7,8,8A-OCTAHYDRO-7-METHYLSPIRO(3,5,8-ETHANYLYLIDENE-1H-PYRANO(3,4-C)PYRIDINE-10,3'-(3H)INDOL)-2'(1'H)-ONE
Systematic Name English
GELSEMINE [MI]
Common Name English
SPIRO(3,5,8-ETHANYLYLIDENE-1H-PYRANO(3,4-C)PYRIDINE-10,3'-(3H)INDOL)-2'(1'H)-ONE, 5-ETHENYL-3,4,4A,5,6,7,8,8A-OCTAHYDRO-7-METHYL-, (3R-(3.ALPHA.,4A.BETA.,5.ALPHA.,8.ALPHA.,8.ABETA.,9S*,10S*))-
Systematic Name English
Gelsemine [WHO-DD]
Common Name English
GELSEMIN [HSDB]
Common Name English
GELSEMINE, (+)-
Systematic Name English
NSC-21729
Code English
Code System Code Type Description
ECHA (EC/EINECS)
208-095-2
Created by admin on Sat Dec 16 07:57:46 GMT 2023 , Edited by admin on Sat Dec 16 07:57:46 GMT 2023
PRIMARY
WIKIPEDIA
Gelsemine
Created by admin on Sat Dec 16 07:57:46 GMT 2023 , Edited by admin on Sat Dec 16 07:57:46 GMT 2023
PRIMARY
FDA UNII
5Y13A78Z72
Created by admin on Sat Dec 16 07:57:46 GMT 2023 , Edited by admin on Sat Dec 16 07:57:46 GMT 2023
PRIMARY
MERCK INDEX
m5688
Created by admin on Sat Dec 16 07:57:46 GMT 2023 , Edited by admin on Sat Dec 16 07:57:46 GMT 2023
PRIMARY Merck Index
NSC
21729
Created by admin on Sat Dec 16 07:57:46 GMT 2023 , Edited by admin on Sat Dec 16 07:57:46 GMT 2023
PRIMARY
CAS
509-15-9
Created by admin on Sat Dec 16 07:57:46 GMT 2023 , Edited by admin on Sat Dec 16 07:57:46 GMT 2023
PRIMARY
PUBCHEM
5390854
Created by admin on Sat Dec 16 07:57:46 GMT 2023 , Edited by admin on Sat Dec 16 07:57:46 GMT 2023
PRIMARY
HSDB
3488
Created by admin on Sat Dec 16 07:57:46 GMT 2023 , Edited by admin on Sat Dec 16 07:57:46 GMT 2023
PRIMARY
EPA CompTox
DTXSID40878487
Created by admin on Sat Dec 16 07:57:46 GMT 2023 , Edited by admin on Sat Dec 16 07:57:46 GMT 2023
PRIMARY